Comparison

(S)-Carvedilol-d4 European Partner

Item no. HY-B0006BS-5mg
Manufacturer MedChem Express
CASRN 2747915-23-5
Amount 5 mg
Quantity options 1 mg 5 mg
Category
Type Chemicals
Specific against other
Citations [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.|[2]Wu T, et al. Protective effects of S-carvedilol on doxorubicin-induced damages to human umbilical vein endothelial cells and rats. J Appl Toxicol. 2019 Aug;39(8):1233-1244.
Smiles O[C@@H](CNC([2H])([2H])C([2H])([2H])OC1=CC=CC=C1OC)COC2=CC=CC(N3)=C2C4=C3C=CC=C4
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias (S)-BM 14190-d4
Shipping Condition Room temperature
Available
Manufacturer - Type
Isotope-Labeled Compounds
Manufacturer - Applications
Neuroscience-Neuromodulation
Manufacturer - Targets
Adrenergic Receptor; Isotope-Labeled Compounds
Shipping Temperature
Room temperature
Molecular Weight
410.50
Product Description
(S)-Carvedilol-d4 is deuterium labeled (S)-Carvedilol. (S)-Carvedilol, the S-enantiomer of Carvedilol, is a non-selective β/α-1 blocker. (S)-Carvedilol exerts protection against the vascular or cardiac toxicity of Doxorubicin (DOX)[1].
Manufacturer - Research Area
Cardiovascular Disease
Solubility
10 mM in DMSO
Manufacturer - Pathway
GPCR/G Protein; Neuronal Signaling; Others
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close